How would you approach therapy for a patient with newly diagnosed non-GC DLBCL with previous anthracycline exposure?  

240-300 mg/m2 prior exposure. How would your management change in young fit/older individuals with comorbidities? Would you obtain interval TTE during treatment? 



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice